First Avenue zone change delayed. Owners of property at 1020-1026 First Avenue have three more months to work out a compromise for use of the property, with six condominiums in development, in an area zoned as single family residential. Arcadia staffers have found a number of areas where the city general plan and zoning map do not agree in designation.
The City Council voted against a proposed 6-unit development of condominiums on First Avenue. This caused some conflict as applicant Hank Jong had received approval for the project until a second check showed the zoning he was relying on conflicted with the general plan.
Planning zone change from commercial to multiple residential approved for condominium project at 1510-1516 S. Baldwin Avenue. The applicant is Hang Jong.
An experimental treatment for Alzheimer's Disease originally developed 5 years ago by Arcadia Dr. William K. Summers has been recommended to the U.S. Food and Drug Administration. The drug is called THA.
Families of 13 Alzheimer's disease patients filed a class action law suit to order the government to approve the drug THA. Dr. William Summers of Arcadia was the first to report that THA was effective against Alzheimer's disease 5 years ago.
The Food and Drug Administration cleared the way Monday for expanded testing of the drug THA, a promising drug to treat Alzheimer's Disease. Arcadia resident Dr. William Summers first reported that THA was beneficial to Alzheimer's patients in 1986 in an article in the New England Journal of Medicine.